ES2185744T3 - Composicion nutritiva. - Google Patents

Composicion nutritiva.

Info

Publication number
ES2185744T3
ES2185744T3 ES96202637T ES96202637T ES2185744T3 ES 2185744 T3 ES2185744 T3 ES 2185744T3 ES 96202637 T ES96202637 T ES 96202637T ES 96202637 T ES96202637 T ES 96202637T ES 2185744 T3 ES2185744 T3 ES 2185744T3
Authority
ES
Spain
Prior art keywords
source
present
omega
fatty acids
intensive care
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96202637T
Other languages
English (en)
Inventor
John Alexander
Debora Gray
David A Mark
Nancy Schmelkin
Diana Twyman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Application granted granted Critical
Publication of ES2185744T3 publication Critical patent/ES2185744T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/13—Burn treatment

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SUMINISTRA UNA FORMULACION NUTRICIONAL ENTERAL QUE CUMPLE CON LOS REQUERIMIENTOS DE NUTRIENTES DE PACIENTES DE CUIDADO INTENSIVO QUIENES PUEDEN TENER COMPROMETIDA LA CAPACIDAD DE ABSORCION. LA INVENCION SE ADAPTA A LAS NECESIDADES UNICAS DE NUTRIENTES DEL PACIENTE QUE SON GENERADAS POR LA REPARACION DE LOS TEJIDOS O LAS NECESIDADES DE CURACION. PARA ESTE EXTREMO, EN UNA REALIZACION LA INVENCION SUMINISTRA UN METODO PARA SUMINISTRAR UN SOPORTE NUTRICIONAL A PACIENTES DE CUIDADOS INTENSIVOS QUE COMPRENDE LOS PASOS DE ADMINISTRAR UNA CANTIDAD TERAPEUTICAMENTE EFECTIVA DE UNA COMPOSICION QUE COMPRENDE: UNA FUENTE DE PROTEINAS, UNA FUENTE DE CARBOHIDRATOS; Y UNA FUENTE DE LIPIDOS QUE INCLUYE UNA FUENTE DE TRIGLICERIDOS DE CADENA MEDIA, UNA FUENTE DE ACIDOS GRASOS OMEGA-3, Y UNA FUENTE DE ACIDOS GRASOS OMEGA-6.
ES96202637T 1995-09-20 1996-09-20 Composicion nutritiva. Expired - Lifetime ES2185744T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/530,877 US5714472A (en) 1993-12-23 1995-09-20 Enternal formulation designed for optimized nutrient absorption and wound healing

Publications (1)

Publication Number Publication Date
ES2185744T3 true ES2185744T3 (es) 2003-05-01

Family

ID=24115344

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96202637T Expired - Lifetime ES2185744T3 (es) 1995-09-20 1996-09-20 Composicion nutritiva.

Country Status (7)

Country Link
US (1) US5714472A (es)
EP (1) EP0764405B1 (es)
AT (1) ATE227520T1 (es)
DE (1) DE69624768T2 (es)
DK (1) DK0764405T3 (es)
ES (1) ES2185744T3 (es)
PT (1) PT764405E (es)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69612011T3 (de) * 1995-11-24 2010-02-18 Unilever N.V. Zusammensetzung auf basis von fischöl
US6207713B1 (en) * 1997-09-17 2001-03-27 Eric T. Fossel Topical and oral delivery of arginine to cause beneficial effects
US7914814B2 (en) * 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
US7629384B2 (en) * 1997-09-17 2009-12-08 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
DE19757414A1 (de) 1997-12-23 1999-07-01 Nutricia Nv Fettmischung
US6200950B1 (en) 1998-02-18 2001-03-13 Nestec S.A. Calorically dense nutritional composition
US6288116B1 (en) * 1998-05-13 2001-09-11 Novartis Nutrition Ag Method of administration of a nutritional product to a person having renal failure
US6630159B2 (en) * 1999-02-23 2003-10-07 The Procter & Gamble Company Limiting weight gain of cats by feeding carbohydrate source that excludes rice
US7001618B1 (en) * 1999-07-09 2006-02-21 The Iams Company Nutritional composition for weight management
US6592863B2 (en) * 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
CA2439293A1 (en) * 2001-03-05 2002-09-12 Stephen P. Ernest Enteral formulation
KR100441851B1 (ko) * 2001-06-04 2004-07-27 안강호 코로나 방전을 이용한 입자의 제조장치 및 그 제조방법
US6605310B2 (en) 2001-06-06 2003-08-12 Nestec S.A. Calorically dense liquid oral supplement
US20030104033A1 (en) * 2001-07-13 2003-06-05 Lai Chon-Si Enteral formulations
MY135783A (en) * 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
TWI317636B (en) * 2002-11-22 2009-12-01 Meiji Dairies Corp Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress
JP2007500208A (ja) * 2003-05-22 2007-01-11 エヌ．ブイ．・ヌートリシア 慢性創傷の治療方法又は予防方法並びにそれに使用するためのグリシン及び／又はロイシンを含む完全栄養組成物
EP1543735B1 (en) * 2003-12-20 2015-10-07 Nestec S.A. Nutritional composition for wound healing
EP1732577B1 (en) * 2004-02-23 2013-04-10 Strategic Science & Technologies, LLC Topical delivery of l-arginine to improve body and skin appearance
US9050365B2 (en) 2004-04-19 2015-06-09 Strategic Science & Technologies, Llc Transdermal delivery of beneficial substances effected by a hostile biophysical environment
US20110028548A1 (en) * 2004-04-19 2011-02-03 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US20090105336A1 (en) * 2004-04-19 2009-04-23 Strategic Science & Technologies, Llc Beneficial Effects of Increasing Local Blood Flow
US9179702B2 (en) 2005-07-13 2015-11-10 Abbott Laboratories Liquid nutritional compositions containing unsaturated fatty acids
PL1981358T3 (pl) * 2006-01-31 2011-04-29 Nestec Sa Kompozycja żywieniowa dla noworodków z niską wagą urodzeniową
FR2918543A1 (fr) * 2007-07-09 2009-01-16 Routinsa Sa Compositions alimentaires enrichies en acides insatures a base de graines d'oleagineux.
US20100292330A1 (en) * 2007-10-04 2010-11-18 Yuanlong Pan Compositions and methods for enhancing cognitive function
US10576110B2 (en) * 2009-05-11 2020-03-03 Societe Des Produits Nestle S.A. Lactobacillus johnsonii La1 NCC533 (CNCM I-1225) and immune disorders
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
WO2010149759A1 (en) 2009-06-24 2010-12-29 Basf Se Microparticles comprising a fat soluble fraction comprising dha and their production
WO2010151241A1 (en) 2009-06-24 2010-12-29 Strategic Science & Technologies, Llc Topical composition containing naproxen
EP3045171A1 (en) * 2009-06-24 2016-07-20 Strategic Science & Technologies, LLC Topical composition
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US20120308525A1 (en) * 2009-11-25 2012-12-06 Nestec S.A. Nutritional compositions including a high protein component and exogenous nucleotides
CN103442723A (zh) 2010-12-29 2013-12-11 战略科学与技术有限责任公司 治疗变态反应和其它适应症的系统和方法
CN105920603B (zh) 2010-12-29 2022-02-11 战略科学与技术有限责任公司 勃起功能障碍和其它适应症的治疗
CN103347403B (zh) 2011-02-02 2016-04-20 雀巢产品技术援助有限公司 高蛋白质营养组合物及其制备和应用方法
WO2012138212A1 (en) * 2011-04-06 2012-10-11 N.V. Nutricia Food composition for intra-operative tube feeding
US20210176999A1 (en) 2011-04-17 2021-06-17 Omega Foods, LLC Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
AU2016219070B2 (en) 2015-02-13 2020-06-11 Mars, Incorporated Pet food feeding system
EP3411016B1 (en) * 2016-02-03 2024-09-11 Fresenius Kabi Deutschland GmbH High caloric, high protein nutritional formula
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
MX2020001765A (es) 2017-08-14 2020-07-29 Axcella Health Inc Composiciones de aminoacidos para el tratamiento de enfermedad hepatica.
US10743574B2 (en) * 2018-06-18 2020-08-18 Orgalife Nutrition Science Company Limited Oral/enteral nutritious foods and method of manufacturing the same
CN112839643A (zh) 2018-06-20 2021-05-25 胺细拉健康公司 用于治疗肌肉中脂肪浸润的组合物及方法
DE102018124227A1 (de) 2018-10-01 2020-04-02 sanaFactur GmbH Zubereitung zur Verbesserung körpereigener Wundheilung

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459620B1 (fr) * 1979-06-26 1983-08-05 Agronomique Inst Nat Rech Hydrolisat enzymatique total de proteines de lactoserum, obtention et application
FR2474828B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere premiere a base de caseine, contenant des phosphocaseinates de cations bivalents, produits obtenus et application
FR2474829B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications
FR2544613B1 (fr) * 1983-04-20 1985-10-25 Roussel Uclaf Nouvelles compositions destinees a etre utilisees en dietetique, en reanimation et en therapeutique, renfermant une fraction proteique a base de trois types de minipeptides
IL77629A (en) * 1985-01-22 1989-07-31 Abbott Lab High fat,low carbohydrate enteral nutritional for mula
US4670268A (en) * 1985-01-29 1987-06-02 Abbott Laboratories Enteral nutritional hypoallergenic formula
AU1489688A (en) * 1987-02-20 1988-09-14 Shriners Hospitals For Crippled Children Omega-3 fatty acids in traumatic injury treatment
US5053387A (en) * 1987-02-20 1991-10-01 Shriners Hospitals For Crippled Children Omega-3 fatty acids in traumatic injury treatment
US5116819A (en) * 1989-05-05 1992-05-26 Clintec Nutrition Co. Enteral diet for patients with pulmonary disease
US5221668A (en) * 1992-02-26 1993-06-22 Abbott Laboratories Nutritional product for trauma and surgery patients

Also Published As

Publication number Publication date
DK0764405T3 (da) 2003-02-10
PT764405E (pt) 2003-03-31
US5714472A (en) 1998-02-03
EP0764405B1 (en) 2002-11-13
DE69624768D1 (de) 2002-12-19
EP0764405A3 (en) 1998-04-29
DE69624768T2 (de) 2003-10-02
ATE227520T1 (de) 2002-11-15
EP0764405A2 (en) 1997-03-26

Similar Documents

Publication Publication Date Title
ES2185744T3 (es) Composicion nutritiva.
US5198468A (en) Essential fatty acid composition
IT8423086A1 (it) Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
DE69506642D1 (de) Pharmazeutische Zubereitungen enthaltend mehrfach ungesättigte Fettsäuren zusammen mit antioxydativen Vitaminen und Provitaminen
BR0112073A (pt) Combinações terapêuticas de ácidos graxos
IE891819L (en) Essential fatty acid compositions
DK0691079T3 (da) Enteral komposition til diabetespatienter
CA2104567A1 (en) Fatty acid treatment
ATE55905T1 (de) Mittel zur behandlung und zum schutz der haut.
NZ250583A (en) Pharmaceutical, nutritional, or skin care compositions containing an ester of a cholesterol and fatty acid
CA2231525A1 (en) Nutritional support of paediatric patients
DE69114498D1 (de) Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen.
DE69433713D1 (de) Für die behandlung neurologischer erkrankungen nützliche methoden und pharmazeutische zusammensetzungen
DK0780124T3 (da) Farmaceutisk præparat omfattende et alkanoyl-L-carnitin sammen med en polyumættet fedtsyre fra omega-3-serien til forebyggelse og behandling af lipidmetabolisme-lidelser
IL137848A0 (en) Indole-3-propionic acids, salts and esters thereof used as medicaments
ITMI951359A0 (it) Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali
ATE143261T1 (de) Zusammensetzung zur behandlung entzündlicher darmerkrankungen
DE60008127D1 (de) Diät mit hohem lipidgehalt
ATE50499T1 (de) Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.
AU633618B2 (en) Fatty acid therapy
FI896321A7 (fi) Aktiiviainetta sisältävät mikrorakeet, jotka koostuvat pääasiassa kyllästettyjen rasvahappojen triglyseridistä, ja niiden käyttö paikallisesti sairaanhoitoalalla
AU7438287A (en) Omega-3 fatty acid aided reduction of cyclosporin mephrotoxicity
Campbell Clinical use of fatty acid supplements in dogs
AU1300001A (en) Gastroresistant tablets for alimentary, dietetic and therapeutic use
ATE293895T1 (de) Faserige lipo-ernährungskomplexe und diese enthaltende zusammensetzungen